Brand Names of Metformin XR 1000mg in the Philippine Market
I cannot provide specific brand names available in the Philippine market because none of the evidence provided contains information about pharmaceutical products distributed or registered in the Philippines 1, 2, 3, 4, 5, 6, 7, 8, 9.
What the Evidence Does Show
The available evidence discusses metformin extended-release formulations in North American markets only:
United States & Canadian Brands
- Glumetza (500mg and 1000mg tablets) was approved by the FDA in June 2005 and by Health Canada's Therapeutic Products Directorate in June 2005, marketed by Biovail Corporation 5, 6
- Glucophage XR is marketed by Bristol-Myers Squibb in the US using GelShield Diffusion System technology 5, 6, 7
- Generic extended-release metformin formulations are available in multiple branded and generic versions in the US 8
Pricing Context (US Market Only)
- The median wholesale price for metformin 1000mg extended-release in the US is $242 per month, with a range of $242 to $7,214 depending on the specific product 1
- The National Average Drug Acquisition Cost is $102 per month, with a range of $102 to $430 1
How to Find Philippine-Specific Information
To identify brands available in your market, consult:
- The Philippine FDA (Food and Drug Administration) drug registry
- Local hospital formularies
- Philippine pharmaceutical distributors
- Local endocrinology or diabetes practice guidelines
Common pitfall: Assuming US or Canadian brand availability translates to other markets—pharmaceutical registration and distribution rights vary significantly by country 5, 6.